Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is among the most common human malignancies. METHODS: In order to provide better understanding of the molecular biology of ccRCC and to identify potential diagnostic/prognostic biomarker and therapeutic targets, we utilized a microarray to profile...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Cancer
Auteurs principaux: Schrödter, Sarah, Braun, Martin, Syring, Isabella, Klümper, Niklas, Deng, Mario, Schmidt, Doris, Perner, Sven, Müller, Stefan C, Ellinger, Jörg
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736613/
https://ncbi.nlm.nih.gov/pubmed/26831905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0495-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires